Writing/Quadratín Mexico
MEXICO CITY, November 19, 2022.- The Federal Commission for Protection from Health Risks (Cofepris) has deemed appropriate the emergency use authorization of the Soberana vaccine and Soberana PL for adults, with the distinguishing names: recombinant domain protein SARS-CoV-2 binding to tetanus toxoid conjugated virus receptor (RBD); and recombinant SARS-CoV-2 virus receptor binding domain (RBD) protein.
Through a statement, he explained that the authorizations he issues are part of the National Health Regulatory Strategy, which allows you to review and give access to the largest number of health supplies, as long as the quality, safety and efficacy of the product is verified.
The complete note in Mexican square